Traumatic brain injury enhances neuroinflammation and lesion volume in caveolin deficient mice

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Niesman, Ingrid R ^a,b   Schilling, Jan M ^a,b   Shapiro, Lee A ^c,d   Kellerhals, Sarah E ^a,b   Bonds, Jacqueline A ^a,b   Kleschevnikov, Alexander M ^e   Cui, Weihua ^a,b,g   Voong, April ^a,b   Krajewski, Stan ^f   Ali, Sameh S ^a,b,h   Roth, David M ^a,b   Patel, Hemal H ^a,b   Patel, Piyush M ^a,b   Head, Brian P ^a,b  

^a VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^b University of California at San Diego   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

^d TEXAS A M COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f BURNHAM INSTITUTE   (United States)

^g CAPITAL MEDICAL UNIVERSITY   (China)

^h Zewail City of Science and Technology   (Egypt)

Author keywords

[No Author keywords available]

Indexed keywords

BRAIN PROTEIN; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; INTERLEUKIN 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL ACTIVATION; CELL POPULATION; CONTROLLED STUDY; ELECTRON SPIN RESONANCE; ENZYME ACTIVITY; FRACTIONATION; HIPPOCAMPUS; HISTOPATHOLOGY; IMMUNOFLUORESCENCE MICROSCOPY; MALE; MICROGLIA; MOUSE; NERVOUS SYSTEM INFLAMMATION; NONHUMAN; OPEN FIELD BEHAVIOR; PARIETAL CORTEX; PROTEIN LOCALIZATION; TRAUMATIC BRAIN INJURY; WILD TYPE;

ANIMALS; BRAIN; BRAIN INJURIES; CAVEOLIN 1; CAVEOLIN 3; CELLS, CULTURED; COGNITION DISORDERS; CYTOKINES; DISEASE MODELS, ANIMAL; ENCEPHALITIS; FUNCTIONAL LATERALITY; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MOVEMENT DISORDERS; NADPH OXIDASE; NEURONS; SYNAPTOSOMES;

EID: 84897960497     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-39     Document Type: Article

References (68)

1. Narayan RK, Michel ME, Ansell B, Baethmann A, Biegon A, Bracken MB, Bullock MR, Choi SC, Clifton GL, Contant CF, Coplin WM, Dietrich WD, Ghajar J, Grady SM, Grossman RG, Hall ED, Heetderks W, Hovda DA, Jallo J, Katz RL, Knoller N, Kochanek PM, Maas AI, Majde J, Marion DW, Marmarou A, Marshall LF, McIntosh TK, Miller E, Mohberg N, et al. Clinical trials in head injury. J Neurotrauma 2002, 19:503-557. 10.1089/089771502753754037, 1462953, 12042091.
2. Atkins CM, Falo MC, Alonso OF, Bramlett HM, Dietrich WD. Deficits in ERK and CREB activation in the hippocampus after traumatic brain injury. Neurosci Lett 2009, 459:52-56. 10.1016/j.neulet.2009.04.064, 2695936, 19416748.
3. Biegon A, Fry PA, Paden CM, Alexandrovich A, Tsenter J, Shohami E. Dynamic changes in N-methyl-D-aspartate receptors after closed head injury in mice: implications for treatment of neurological and cognitive deficits. Proc Natl Acad Sci U S A 2004, 101:5117-5122. 10.1073/pnas.0305741101, 387383, 15044697.
4. Conte V, Raghupathi R, Watson DJ, Fujimoto S, Royo NC, Marklund N, Stocchetti N, McIntosh TK. TrkB gene transfer does not alter hippocampal neuronal loss and cognitive deficits following traumatic brain injury in mice. Restor Neurol Neurosci 2008, 26:45-56. 2580053, 18431005.
5. Hicks RR, Zhang L, Dhillon HS, Prasad MR, Seroogy KB. Expression of trkB mRNA is altered in rat hippocampus after experimental brain trauma. Brain Res Mol Brain Res 1998, 59:264-268. 10.1016/S0169-328X(98)00158-2, 9729420.
6. Brambilla R, Cottini L, Fumagalli M, Ceruti S, Abbracchio MP. Blockade of A2A adenosine receptors prevents basic fibroblast growth factor-induced reactive astrogliosis in rat striatal primary astrocytes. Glia 2003, 43:190-194. 10.1002/glia.10243, 12838511.
7. Orr AG, Orr AL, Li XJ, Gross RE, Traynelis SF. Adenosine A(2A) receptor mediates microglial process retraction. Nat Neurosci 2009, 12:872-878. 10.1038/nn.2341, 2712729, 19525944.
8. Talley Watts L, Sprague S, Zheng W, Garling RJ, Jimenez D, Digicaylioglu M, Lechleiter J. Purinergic 2Y1 receptor stimulation decreases cerebral edema and reactive gliosis in a traumatic brain injury model. J Neurotrauma 2013, 30:55-66. 10.1089/neu.2012.2488, 23046422.
9. Bachstetter AD, Rowe RK, Kaneko M, Goulding D, Lifshitz J, Van Eldik LJ. The p38alpha MAPK regulates microglial responsiveness to diffuse traumatic brain injury. J Neurosci 2013, 33:6143-6153. 10.1523/JNEUROSCI.5399-12.2013, 3667712, 23554495.
10. Frey LC. Epidemiology of posttraumatic epilepsy: a critical review. Epilepsia 2003, 44(Suppl 10):11-17.
11. Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med 1998, 338:20-24. 10.1056/NEJM199801013380104, 9414327.
12. Beghi E. Overview of studies to prevent posttraumatic epilepsy. Epilepsia 2003, 44(Suppl 10):21-26.
13. Goodrich GS, Kabakov AY, Hameed MQ, Dhamne SC, Rosenberg PA, Rotenberg A. Ceftriaxone treatment after traumatic brain injury restores expression of the glutamate transporter GLT-1, reduces regional gliosis, and reduces posttraumatic seizures in the rat. J Neurotrauma 2013, 30:1434-1441. 10.1089/neu.2012.2712, 23510201.
14. Chidlow JH, Sessa WC. Caveolae, caveolins, and cavins: complex control of cellular signalling and inflammation. Cardiovasc Res 2010, 86:219-225. 10.1093/cvr/cvq075, 2856194, 20202978.
15. Shin T, Kim H, Jin JK, Moon C, Ahn M, Tanuma N, Matsumoto Y. Expression of caveolin-1, -2, and -3 in the spinal cords of Lewis rats with experimental autoimmune encephalomyelitis. J Neuroimmunol 2005, 165:11-20. 10.1016/j.jneuroim.2005.03.019, 15925413.
16. Silva WI, Maldonado HM, Velazquez G, Garcia JO, Gonzalez FA. Caveolins in glial cell model systems: from detection to significance. J Neurochem 2007, 103(Suppl 1):101-112.
17. Stern CM, Mermelstein PG. Caveolin regulation of neuronal intracellular signaling. Cell Mol Life Sci 2010, 67:3785-3795. 10.1007/s00018-010-0447-y, 3740547, 20632068.
18. Mirza MK, Yuan J, Gao XP, Garrean S, Brovkovych V, Malik AB, Tiruppathi C, Zhao YY. Caveolin-1 deficiency dampens toll-like receptor 4 signaling through eNOS activation. Am J Pathol 2010, 176:2344-2351. 10.2353/ajpath.2010.091088, 2861099, 20304961.
19. Head BP, Peart JN, Panneerselvam M, Yokoyama T, Pearn ML, Niesman IR, Bonds JA, Schilling JM, Miyanohara A, Headrick J, Ali SS, Roth DM, Patel PM, Patel HH. Loss of caveolin-1 accelerates neurodegeneration and aging. PLoS One 2010, 5:e15697. 10.1371/journal.pone.0015697, 3009734, 21203469.
20. Niesman IR, Zemke N, Fridolfsson HN, Haushalter KJ, Levy K, Grove A, Schnoor R, Finley JC, Patel PM, Roth DM, Head BP, Patel HH. Caveolin isoform switching as a molecular, structural, and metabolic regulator of microglia. Mol Cell Neurosci 2013, 56:283-297.
21. Hagiwara Y, Sasaoka T, Araishi K, Imamura M, Yorifuji H, Nonaka I, Ozawa E, Kikuchi T. Caveolin-3 deficiency causes muscle degeneration in mice. Hum Mol Genet 2000, 9:3047-3054. 10.1093/hmg/9.20.3047, 11115849.
22. Krajewska M, You Z, Rong J, Kress C, Huang X, Yang J, Kyoda T, Leyva R, Banares S, Hu Y, Sze CH, Whalen MJ, Salmena L, Hakem R, Head BP, Reed JC, Krajewski S. Neuronal deletion of caspase 8 protects against brain injury in mouse models of controlled cortical impact and kainic acid-induced excitotoxicity. PLoS One 2011, 6:e24341. 10.1371/journal.pone.0024341, 3174961, 21957448.
23. Krajewska M, Smith LH, Rong J, Huang X, Hyer ML, Zeps N, Iacopetta B, Linke SP, Olson AH, Reed JC, Krajewski S. Image analysis algorithms for immunohistochemical assessment of cell death events and fibrosis in tissue sections. J Histochem Cytochem 2009, 57:649-663. 10.1369/jhc.2009.952812, 2699321, 19289554.
24. Head BP, Patel HH, Tsutsumi YM, Hu Y, Mejia T, Mora RC, Insel PA, Roth DM, Drummond JC, Patel PM. Caveolin-1 expression is essential for N-methyl-D-aspartate receptor-mediated Src and extracellular signal-regulated kinase 1/2 activation and protection of primary neurons from ischemic cell death. FASEB J 2008, 22:828-840.
25. Head BP, Hu Y, Finley JC, Saldana MD, Bonds JA, Miyanohara A, Niesman IR, Ali SS, Murray F, Insel PA, Roth DM, Patel HH, Patel PM. Neuron-targeted caveolin-1 protein enhances signaling and promotes arborization of primary neurons. J Biol Chem 2011, 286:33310-33321. 10.1074/jbc.M111.255976, 3190943, 21799010.
26. Paylor R, Nguyen M, Crawley JN, Patrick J, Beaudet A, Orr-Urtreger A. Alpha7 nicotinic receptor subunits are not necessary for hippocampal-dependent learning or sensorimotor gating: a behavioral characterization of Acra7-deficient mice. Learn Mem 1998, 5:302-316. 311270, 10454356.
27. Carter RJ, Morton J, Dunnett SB. Motor coordination and balance in rodents. Curr Protoc Neurosci 2001, Chapter 8:Unit 8.12.
28. Deacon RM, Rawlins JN. T-maze alternation in the rodent. Nat Protoc 2006, 1:7-12. 10.1038/nprot.2006.2, 17406205.
29. Sharma S, Rakoczy S, Brown-Borg H. Assessment of spatial memory in mice. Life Sci 2010, 87:521-536. 10.1016/j.lfs.2010.09.004, 20837032.
30. Kleschevnikov AM, Belichenko PV, Faizi M, Jacobs LF, Htun K, Shamloo M, Mobley WC. Deficits in cognition and synaptic plasticity in a mouse model of down syndrome ameliorated by GABAB receptor antagonists. J Neurosci 2012, 32:9217-9227. 10.1523/JNEUROSCI.1673-12.2012, 3411326, 22764230.
31. Ali SS, Young JW, Wallace CK, Gresack J, Jeste DV, Geyer MA, Dugan LL, Risbrough VB. Initial evidence linking synaptic superoxide production with poor short-term memory in aged mice. Brain Res 2011, 1368:65-70. 3018762, 21075081.
32. Mukherjee S, Katki K, Arisi GM, Foresti ML, Shapiro LA. Early TBI-induced cytokine alterations are similarly detected by two distinct methods of multiplex assay. Front Mol Neurosci 2011, 4:21. 3174383, 21954376.
33. Truong TQ, Aubin D, Bourgeois P, Falstrault L, Brissette L. Opposite effect of caveolin-1 in the metabolism of high-density and low-density lipoproteins. Biochim Biophys Acta 2006, 1761:24-36. 10.1016/j.bbalip.2005.12.004, 16443388.
34. Wu L, Gonias SL. The low-density lipoprotein receptor-related protein-1 associates transiently with lipid rafts. J Cell biochem 2005, 96:1021-1033. 10.1002/jcb.20596, 16149055.
35. Neary JT, Kang Y, Tran M, Feld J. Traumatic injury activates protein kinase B/Akt in cultured astrocytes: role of extracellular ATP and P2 purinergic receptors. J Neurotrauma 2005, 22:491-500. 10.1089/neu.2005.22.491, 15853465.
36. Huang T, Solano J, He D, Loutfi M, Dietrich WD, Kuluz JW. Traumatic injury activates MAP kinases in astrocytes: mechanisms of hypothermia and hyperthermia. J Neurotrauma 2009, 26:1535-1545. 10.1089/neu.2008.0743, 19331517.
37. Jasmin JF, Rengo G, Lymperopoulos A, Gupta R, Eaton GJ, Quann K, Gonzales DM, Mercier I, Koch WJ, Lisanti MP. Caveolin-1 deficiency exacerbates cardiac dysfunction and reduces survival in mice with myocardial infarction. Am J Physiol Heart Circ Physiol 2011, 300:H1274-H1281. 10.1152/ajpheart.01173.2010, 3075024, 21297026.
38. Gu Y, Zheng G, Xu M, Li Y, Chen X, Zhu W, Tong Y, Chung SK, Liu KJ, Shen J. Caveolin-1 regulates nitric oxide-mediated matrix metalloproteinases activity and blood-brain barrier permeability in focal cerebral ischemia and reperfusion injury. J Neurochem 2012, 120:147-156. 10.1111/j.1471-4159.2011.07542.x, 22007835.
39. Gioiosa L, Raggi C, Ricceri L, Jasmin JF, Frank PG, Capozza F, Lisanti MP, Alleva E, Sargiacomo M, Laviola G. Altered emotionality, spatial memory and cholinergic function in caveolin-1 knock-out mice. Behav Brain Res 2008, 188:255-262. 10.1016/j.bbr.2007.11.002, 18083242.
40. Adewuya AO, Oseni SB. Impact of psychiatric morbidity on parent-rated quality of life in Nigerian adolescents with epilepsy. Epilepsy Behav 2005, 7:497-501. 10.1016/j.yebeh.2005.07.011, 16143568.
41. Duchowny M, Jayakar P, Levin B. Aberrant neural circuits in malformations of cortical development and focal epilepsy. Neurology 2000, 55:423-428. 10.1212/WNL.55.3.423, 10932280.
42. Babb TL, Ying Z, Mikuni N, Nishiyama K, Drazba J, Bingaman W, Wyllie E, Wylie CJ, Yacubova K. Brain plasticity and cellular mechanisms of epileptogenesis in human and experimental cortical dysplasia. Epilepsia 2000, 41(Suppl 6):S76-S81.
43. Kim JH, Jang BG, Choi BY, Kim HS, Sohn M, Chung TN, Choi HC, Song HK, Suh SW. Post-treatment of an NADPH oxidase inhibitor prevents seizure-induced neuronal death. Brain Res 2013, 1499:163-172.
44. Cheret C, Gervais A, Lelli A, Colin C, Amar L, Ravassard P, Mallet J, Cumano A, Krause KH, Mallat M. Neurotoxic activation of microglia is promoted by a nox1-dependent NADPH oxidase. J Neurosci 2008, 28:12039-12051. 10.1523/JNEUROSCI.3568-08.2008, 19005069.
45. Pitkanen A, Lukasiuk K. Molecular and cellular basis of epileptogenesis in symptomatic epilepsy. Epilepsy Behav 2009, 14(Suppl 1):16-25.
46. Pitkanen A, Lukasiuk K. Mechanisms of epileptogenesis and potential treatment targets. Lancet Neurol 2011, 10:173-186. 10.1016/S1474-4422(10)70310-0, 21256455.
47. Schierhout G, Roberts I. Anti-epileptic drugs for preventing seizures following acute traumatic brain injury. Cochrane Database Syst Rev 2001, 4:CD000173.
48. Foresti ML, Arisi GM, Katki K, Montanez A, Sanchez RM, Shapiro LA. Chemokine CCL2 and its receptor CCR2 are increased in the hippocampus following pilocarpine-induced status epilepticus. J Neuroinflammation 2009, 6:40. 10.1186/1742-2094-6-40, 2804573, 20034406.
49. Semple BD, Bye N, Rancan M, Ziebell JM, Morganti-Kossmann MC. Role of CCL2 (MCP-1) in traumatic brain injury (TBI): evidence from severe TBI patients and CCL2-/- mice. J Cerebral Blood Flow Metabol 2010, 30:769-782.
50. Andjelkovic AV, Song L, Dzenko KA, Cong H, Pachter JS. Functional expression of CCR2 by human fetal astrocytes. J Neurosci Res 2002, 70:219-231. 10.1002/jnr.10372, 12271471.
51. Ge S, Pachter JS. Caveolin-1 knockdown by small interfering RNA suppresses responses to the chemokine monocyte chemoattractant protein-1 by human astrocytes. J Biol Chem 2004, 279:6688-6695.
52. Guzik-Kornacka A, Sliwa A, Plucinska G, Lukasiuk K. Status epilepticus evokes prolonged increase in the expression of CCL3 and CCL4 mRNA and protein in the rat brain. Acta Neurobiolog Experimental 2011, 71:193-207.
53. Patel HH, Murray F, Insel PA. G-protein-coupled receptor-signaling components in membrane raft and caveolae microdomains. Handb Exp Pharmacol 2008, 186:167-184. 10.1007/978-3-540-72843-6_7, 18491052.
54. Hasko G, Pacher P, Vizi ES, Illes P. Adenosine receptor signaling in the brain immune system. Trends Pharmacol Sci 2005, 26:511-516. 10.1016/j.tips.2005.08.004, 2228262, 16125796.
55. Fields RD, Burnstock G. Purinergic signalling in neuron-glia interactions. Nat Rev Neurosci 2006, 7:423-436. 10.1038/nrn1928, 2062484, 16715052.
56. Boison D, Chen JF, Fredholm BB. Adenosine signaling and function in glial cells. Cell Death Differ 2010, 17:1071-1082. 10.1038/cdd.2009.131, 2885470, 19763139.
57. Fedele DE, Li T, Lan JQ, Fredholm BB, Boison D. Adenosine A1 receptors are crucial in keeping an epileptic focus localized. Exp Neurol 2006, 200:184-190. 10.1016/j.expneurol.2006.02.133, 16750195.
58. Kochanek PM, Vagni VA, Janesko KL, Washington CB, Crumrine PK, Garman RH, Jenkins LW, Clark RS, Homanics GE, Dixon CE, Schnermann J, Jackson EK. Adenosine A1 receptor knockout mice develop lethal status epilepticus after experimental traumatic brain injury. J Cerebral Blood Flow Metabol 2006, 26:565-575.
59. Ribeiro JA, Sebastiao AM, de Mendonca A. Adenosine receptors in the nervous system: pathophysiological implications. Prog Neurobiol 2002, 68:377-392. 10.1016/S0301-0082(02)00155-7, 12576292.
60. Shen HY, Chen JF. Adenosine A(2A) receptors in psychopharmacology: modulators of behavior, mood and cognition. Curr Neuropharmacol 2009, 7:195-206. 10.2174/157015909789152191, 2769003, 20190961.
61. Dixon AK, Widdowson L, Richardson PJ. Desensitisation of the adenosine A1 receptor by the A2A receptor in the rat striatum. J Neurochem 1997, 69:315-321.
62. Gomes C, Ferreira R, George J, Sanches R, Rodrigues DI, Goncalves N, Cunha RA. Activation of microglial cells triggers a release of brain-derived neurotrophic factor (BDNF) inducing their proliferation in an adenosine A2A receptor-dependent manner: A2A receptor blockade prevents BDNF release and proliferation of microglia. J Neuroinflammation 2013, 10:16. 10.1186/1742-2094-10-16, 3567964, 23363775.
63. Di Virgilio F, Ceruti S, Bramanti P, Abbracchio MP. Purinergic signalling in inflammation of the central nervous system. Trends Neurosci 2009, 32:79-87. 10.1016/j.tins.2008.11.003, 19135728.
64. Heverin M, Engel T, Meaney S, Jimenez-Mateos EM, Al-Saudi R, Henshall DC. Bi-lateral changes to hippocampal cholesterol levels during epileptogenesis and in chronic epilepsy following focal-onset status epilepticus in mice. Brain Res 2012, 1480:81-90.
65. Biagini G, Marinelli C, Panuccio G, Puia G, Avoli M. Glia-neuron interactions: neurosteroids and epileptogenesis. Jasper's Basic mechanisms of the epilepsies 2012, Bethesda MD: National Center for Biotechnology Information (US), Noebels JL, Avoli M, Rogawski MA, Olsen RW, Delgado-Escueta AV, 4, http://www.ncbi.nlm.nih.gov/books/NBK98132/.
66. Adibhatla RM, Hatcher JF. Altered lipid metabolism in brain injury and disorders. Subcell Biochem 2008, 49:241-268. 10.1007/978-1-4020-8831-5_9, 2293298, 18751914.
67. Diaz-Arrastia R, Gong Y, Fair S, Scott KD, Garcia MC, Carlile MC, Agostini MA, Van Ness PC. Increased risk of late posttraumatic seizures associated with inheritance of APOE epsilon4 allele. Arch Neurol 2003, 60:818-822. 10.1001/archneur.60.6.818, 12810485.
68. Spuch C, Ortolano S, Navarro C. LRP-1 and LRP-2 receptors function in the membrane neuron: trafficking mechanisms and proteolytic processing in Alzheimer's disease. Front Physiol 2012, 3:269. 3429044, 22934024.